GeneDx Holdings Corp. (WGS) Stock Ticker
WGS right now
Market factors today
Unlock the full WGS picture
About GeneDx Holdings Corp.
GeneDx Holdings Corp., a genomics company, provides genetic testing services. The company primarily offers pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing, as well as data and information services. It also develops an AI-based platform for next generation sequencing analysis, interpretation, and clinical reporting for rare disease, hereditary risk, and cancer testing. GeneDx Holdings Corp. was founded in 2000 and is headquartered in Stamford, Connecticut.
WGS stock facts
| Ticker symbol | WGS |
| Exchange | NASDAQ Global Market |
| Sector | Healthcare |
| Industry | Medical - Diagnostics & Research |
| Market cap | $2.6B |
| CEO | Katherine A. Stueland |
| Employees | 1,300 |
| Headquarters | Stamford, CT, US |
| IPO date | 2020-11-04 |
| Website | www.genedx.com |
What you can see for WGS on Tickr
Live WGS price chart with overlays, the options chain, implied move, IV rank, options flow and Strategy Lab, financial statements and consensus estimates, analyst ratings, catalysts, news with AI scoring, and an AI chat that has read the WGS report.
Rankings
FAQ
What is the ticker symbol for GeneDx Holdings Corp.?
The ticker symbol for GeneDx Holdings Corp. is WGS, listed on the NASDAQ Global Market.
What is WGS?
GeneDx Holdings Corp., a genomics company, provides genetic testing services. The company primarily offers pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing, as well as data and information services. It also develops an AI-based platform for next generation sequencing analysis, interpretation, and clinical reporting for rare disease, hereditary risk, and…